AI assistant
Sending…
CYTOKINETICS INC — Director's Dealing 2024
Jan 4, 2024
30870_dirs_2024-01-04_50a54f6f-9a80-4a2a-848f-3579bdb34055.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2024-01-04
Reporting Person: Malik Fady Ibraham (EVP Research & Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-01-04 | Common Stock | M | 11678 | $7.96 | Acquired | 162651 | Direct |
| 2024-01-04 | Common Stock | S | 11678 | $86.98 | Disposed | 150973 | Direct |
| 2024-01-04 | Common Stock | S | 4000 | $86.99 | Disposed | 146973 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-01-04 | Incentive Stock Option (Right to Buy) | $7.96 | M | 11678 | Disposed | 2025-02-26 | Common Stock (11678) | Direct |
Footnotes
F1: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 26, 2023.
More from CYTOKINETICS INC
Share Issue/Capital Change
2026
May 27
Declaration of Voting Results & Voting Rights Announcements
2026
May 27
Share Issue/Capital Change
2026
May 7
Report Publication Announcement
2026
May 5
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18